Kymera Therapeutics Presents New Preclinical Data for KT-579 Kymera Therapeutics, Inc., a clinical-stage biopharmaceutical company, announced the presentation of new preclinical data for K…
Introduction to Altermagnetism Experiments have only recently confirmed the existence of altermagnetic materials, but they are already gen…
New Toronto Transit Station to Open A new station serving GO Transit's Kitchener Line and UP Express is set to open in weeks. Metro…
Sivers Semiconductors Achieves Solid Q3 Performance Sivers Semiconductors AB has announced its Q3 2025 results, demonstrating sustained pe…
Navigating Complex Injury Cases Efficiently Dealing with a serious injury case can be stressful and confusing, with nearly 70 percent of p…
World Treadmill Championships to Debut in 2026 The first-ever World Treadmill Championships, dubbed RUN X, will take place over 5km in 202…
The Glimpse Group Launches IPO/Spin-Off Initiative The Glimpse Group, Inc. ("Glimpse") (NASDAQ:VRAR), a diversified Immersive Technology p…
Isuzu FA Trophy Second Round Proper Draw Confirmed The draw for the Isuzu FA Trophy Second Round Proper has been announced, with 40 matche…
OPPO and Ballet Philippines Partnership OPPO has announced a partnership with Ballet Philippines to promote Filipino artistry, marking the…
Dracula Technologies Secures €30M in Series A Round Valence-based Dracula Technologies has announced the successful completion of its Seri…
Neumora Therapeutics Announces Initiation of Phase 1 Clinical Study Neumora Therapeutics, Inc. has initiated a Phase 1 clinical study of N…